These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9169468)

  • 1. Regulation of human apolipoprotein A-I gene expression by gramoxone.
    Cuthbert C; Wang Z; Zhang X; Tam SP
    J Biol Chem; 1997 Jun; 272(23):14954-60. PubMed ID: 9169468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dimethyl sulfoxide on apolipoprotein A-I in the human hepatoma cell line, HepG2.
    Tam SP; Zhang X; Cuthbert C; Wang Z; Ellis T
    J Lipid Res; 1997 Oct; 38(10):2090-102. PubMed ID: 9374131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-DNA interactions at a drug-responsive element of the human apolipoprotein A-I gene.
    Zhang X; Chen ZQ; Wang Z; Mohan W; Tam SP
    J Biol Chem; 1996 Oct; 271(43):27152-60. PubMed ID: 8900208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen regulation of the apolipoprotein AI gene promoter through transcription cofactor sharing.
    Harnish DC; Evans MJ; Scicchitano MS; Bhat RA; Karathanasis SK
    J Biol Chem; 1998 Apr; 273(15):9270-8. PubMed ID: 9535920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human apolipoprotein A-I gene expression by equine estrogens.
    Zhang X; Jiao JJ; Bhavnani BR; Tam SP
    J Lipid Res; 2001 Nov; 42(11):1789-800. PubMed ID: 11714848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apolipoprotein A-I gene expression in Hep G2 cells depleted of Cu by cupruretic tetramine.
    Wu JY; Zhang JJ; Wang Y; Reaves SK; Wang YR; Lei PP; Lei KY
    Am J Physiol; 1997 Oct; 273(4):C1362-70. PubMed ID: 9357782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase inhibition is associated with downregulation of apolipoprotein AI promoter activity in cultured hepatoma cell line HepG2.
    Horani MH; Gobal F; Haas MJ; Wong NC; Mooradian AD
    Metabolism; 2004 Feb; 53(2):174-81. PubMed ID: 14767868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional induction of rat liver apolipoprotein A-I gene expression by glucocorticoids requires the glucocorticoid receptor and a labile cell-specific protein.
    Saladin R; Vu-Dac N; Fruchart JC; Auwerx J; Staels B
    Eur J Biochem; 1996 Jul; 239(2):451-9. PubMed ID: 8706754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. E1A represses apolipoprotein AI enhancer activity in liver cells through a pRb- and CBP-independent pathway.
    Kilbourne EJ; Evans MJ; Karathanasis SK
    Nucleic Acids Res; 1998 Apr; 26(7):1761-8. PubMed ID: 9512550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of apolipoprotein AI gene transcription by the liver-enriched factor HNF-3.
    Harnish DC; Malik S; Karathanasis SK
    J Biol Chem; 1994 Nov; 269(45):28220-6. PubMed ID: 7961760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of apolipoprotein AI gene expression in HepG2 cells by TNF alpha and IL-1beta.
    Haas MJ; Horani M; Mreyoud A; Plummer B; Wong NC; Mooradian AD
    Biochim Biophys Acta; 2003 Oct; 1623(2-3):120-8. PubMed ID: 14572909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A bifunctional regulatory element of the human ApoA-I gene responsive to a distal enhancer.
    Jones DR; Leffak M
    DNA Cell Biol; 1999 Feb; 18(2):107-19. PubMed ID: 10073570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulatory sequences within the first intron of the chicken apolipoproteinAI (apoAI) gene.
    Bhattacharyya N; Banerjee D
    Gene; 1999 Jul; 234(2):371-80. PubMed ID: 10395911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sp and GATA factors are critical for Apolipoprotein AI downstream enhancer activity in human HepG2 cells.
    Ivanov GS; Kater JM; Jha SH; Stutius EA; Sabharwal R; Tricarico MD; Ginsburg GS; Ozer JS
    Gene; 2003 Dec; 323():31-42. PubMed ID: 14659877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human S mu binding protein-2 binds to the drug response element and transactivates the human apoA-I promoter: role of gemfibrozil.
    Mohan WS; Chen ZQ; Zhang X; Khalili K; Honjo T; Deeley RG; Tam SP
    J Lipid Res; 1998 Feb; 39(2):255-67. PubMed ID: 9507986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo regulation of low-density lipoprotein receptors by estrogen differs at the post-transcriptional level in rat and mouse.
    Srivastava RA; Baumann D; Schonfeld G
    Eur J Biochem; 1993 Sep; 216(2):527-38. PubMed ID: 8375391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glucosamine on apolipoprotein AI mRNA stabilization and expression in HepG2 cells.
    Haas MJ; Wong NC; Mooradian AD
    Metabolism; 2004 Jun; 53(6):766-71. PubMed ID: 15164326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.
    Srivastava RA
    Mol Cell Biochem; 2000 Jun; 209(1-2):125-9. PubMed ID: 10942210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol down-regulates the transcription of microsomal triglyceride transfer protein gene.
    Lin MC; Li JJ; Wang EJ; Princler GL; Kauffman FC; Kung HF
    FASEB J; 1997 Nov; 11(13):1145-52. PubMed ID: 9367349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dietary cholic acid lowers plasma levels of mouse and human apolipoprotein A-I primarily via a transcriptional mechanism.
    Srivastava RA; Srivastava N; Averna M
    Eur J Biochem; 2000 Jul; 267(13):4272-80. PubMed ID: 10866832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.